Exact Mass: 275.1805

Exact Mass Matches: 275.1805

Found 79 metabolites which its exact mass value is equals to given mass value 275.1805, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pyrodone

4-(2-ethylhexyl)-4-azatricyclo[5.2.1.0²,⁶]dec-8-ene-3,5-dione

C17H25NO2 (275.1885)


   
   
   

3-Hydroxyhexanoylcarnitine

3-Hydroxyhexanoylcarnitine

C13H25NO5 (275.1733)


Hydroxyhexanoycarnitine is an acylcarnitine. More specifically, it is an hydroxyhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hydroxyhexanoycarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine hydroxyhexanoycarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Citronellyl anthranilate

6-Octen-1-ol, 3,7-dimethyl-, 1-(2-aminobenzoate)

C17H25NO2 (275.1885)


Citronellyl anthranilate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .

   

4-Hydroxyhexanoycarnitine

3-[(4-hydroxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H25NO5 (275.1733)


4-Hydroxyhexanoycarnitine is an acylcarnitine. More specifically, it is an 4-hydroxyhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxyhexanoycarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hydroxyhexanoycarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. 4-Hydroxyhexanoycarnitine is elevated in the urine of individuals with metabolic syndrome (PMID: 33295818). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(5R)-5-Hydroxyhexanoylcarnitine

3-[(5-hydroxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H25NO5 (275.1733)


(5R)-5-hydroxyhexanoylcarnitine is an acylcarnitine. More specifically, it is an (5R)-5-hydroxyhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5R)-5-hydroxyhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (5R)-5-hydroxyhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. (5R)-5-hydroxyhexanoylcarnitine is elevated in the urine of individuals with metabolic syndrome (PMID: 33295818). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   
   

2,3-Dihydro-Mantella Alkalod 241F

2,3-Dihydro-Mantella Alkalod 241F

C17H25NO2 (275.1885)


   
   

3,4-Dihydro-Mantella Alkalod 241F

3,4-Dihydro-Mantella Alkalod 241F

C17H25NO2 (275.1885)


   
   
   
   

1-[6-(2-hydroxy-2-phenyl-ethyl)-1-methyl-1,2,3,6-tetrahydro-pyridin-2-yl]-propan-2-ol|Sedacrin|Sedinin

1-[6-(2-hydroxy-2-phenyl-ethyl)-1-methyl-1,2,3,6-tetrahydro-pyridin-2-yl]-propan-2-ol|Sedacrin|Sedinin

C17H25NO2 (275.1885)


   

lycobscurine A

lycobscurine A

C17H25NO2 (275.1885)


   

O-methyldihydrojoubertiamine|O-methyldihydrojourbetiamine

O-methyldihydrojoubertiamine|O-methyldihydrojourbetiamine

C17H25NO2 (275.1885)


   

6-[2-(1-hydroxybutyl)-4-methylphenyl]hex-5-enamide

6-[2-(1-hydroxybutyl)-4-methylphenyl]hex-5-enamide

C17H25NO2 (275.1885)


   

N-((R)-3-Hydroxy-decanoyl)-L-serin|N-((R)-3-hydroxy-decanoyl)-L-serine|Serratamic acid|Serrataminsaeure

N-((R)-3-Hydroxy-decanoyl)-L-serin|N-((R)-3-hydroxy-decanoyl)-L-serine|Serratamic acid|Serrataminsaeure

C13H25NO5 (275.1733)


   

2-[6-(2-Hydroxy-propyl)-1-methyl-[2]piperidyl]-1-phenyl-aethanon|2-[6-(2-hydroxy-propyl)-1-methyl-[2]piperidyl]-1-phenyl-ethanone

2-[6-(2-Hydroxy-propyl)-1-methyl-[2]piperidyl]-1-phenyl-aethanon|2-[6-(2-hydroxy-propyl)-1-methyl-[2]piperidyl]-1-phenyl-ethanone

C17H25NO2 (275.1885)


   

Hydroxy-??-Sanshool

Hydroxy-??-Sanshool

C17H25NO2 (275.1885)


   
   

N-(3S-hydroxydecanoyl)-L-serine

N-(3S-hydroxydecanoyl)-L-serine

C13H25NO5 (275.1733)


   

Serratamic acid

N-(3S-hydroxydecanoyl)-L-serine

C13H25NO5 (275.1733)


   

CAR 6:0;O

(3S)-3-[(3-hydroxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H25NO5 (275.1733)


   

4-Decylphenyl isothiocyanate

4-Decylphenyl isothiocyanate

C17H25NS (275.1708)


   

1,2,5-Trimethyl-4-phenyl-4-propionoxypiperidine

[(2S,5R)-1,2,5-trimethyl-4-phenylpiperidin-4-yl] propanoate

C17H25NO2 (275.1885)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Betameprodina

(3-ethyl-1-methyl-4-phenylpiperidin-4-yl) propanoate

C17H25NO2 (275.1885)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

ethyl 4-[(benzylamino)methyl]cyclohexanecarboxylate

ethyl 4-[(benzylamino)methyl]cyclohexanecarboxylate

C17H25NO2 (275.1885)


   

5,6-Dimethoxy-2-[(4-piperidyl)methyl]indane

5,6-Dimethoxy-2-[(4-piperidyl)methyl]indane

C17H25NO2 (275.1885)


   

N-(4-TERT-BUTYLBENZYL)PIPERIDINE-4-CARBOXYLIC ACID

N-(4-TERT-BUTYLBENZYL)PIPERIDINE-4-CARBOXYLIC ACID

C17H25NO2 (275.1885)


   

Propipocaine

Propipocaine

C17H25NO2 (275.1885)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

tert-butyl 2-benzylpiperidine-1-carboxylate

tert-butyl 2-benzylpiperidine-1-carboxylate

C17H25NO2 (275.1885)


   

(1,3-dimethyl-4-phenylazepan-4-yl) propanoate

(1,3-dimethyl-4-phenylazepan-4-yl) propanoate

C17H25NO2 (275.1885)


   

tert-butyl (3S)-4-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate

tert-butyl (3S)-4-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate

C13H25NO5 (275.1733)


   

5-(4-methoxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane

5-(4-methoxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane

C17H25NO2 (275.1885)


   

2-[4-(2-methylpropyl)phenyl]-1-morpholin-4-ylpropan-1-one

2-[4-(2-methylpropyl)phenyl]-1-morpholin-4-ylpropan-1-one

C17H25NO2 (275.1885)


   

Boc-O-tert-butyl-L-threonine

Boc-O-tert-butyl-L-threonine

C13H25NO5 (275.1733)


   

methyl 2-(nonylideneamino)benzoate

methyl 2-(nonylideneamino)benzoate

C17H25NO2 (275.1885)


   

2-(pyrrolidin-1-yl)pyrimidine-5-boronic acid pinacol ester

2-(pyrrolidin-1-yl)pyrimidine-5-boronic acid pinacol ester

C14H22BN3O2 (275.1805)


   

isononanal / methyl anthranilate schiffs base

isononanal / methyl anthranilate schiffs base

C17H25NO2 (275.1885)


   

Menthyl anthranilate

Menthyl anthranilate

C17H25NO2 (275.1885)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

2-Methyl-2-propanyl N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-homoserinate

2-Methyl-2-propanyl N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-homoserinate

C13H25NO5 (275.1733)


   

Boc-D-Thr(tBu)-OH

Boc-D-Thr(tBu)-OH

C13H25NO5 (275.1733)


   

Alphameprodine

[(3S,4R)-3-ethyl-1-methyl-4-phenylpiperidin-4-yl] propanoate

C17H25NO2 (275.1885)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

5-[(1-Phenylcyclohexyl)amino]pentanoic acid

5-[(1-Phenylcyclohexyl)amino]pentanoic acid

C17H25NO2 (275.1885)


A fatty acid derivative consisting of valeric acid substituted at C-5 with an N-(1-phenylcyclohexyl)amino group.

   

3-Hydroxyhexanoylcarnitine

3-Hydroxyhexanoylcarnitine

C13H25NO5 (275.1733)


Hydroxyhexanoycarnitine is an acylcarnitine. More specifically, it is an hydroxyhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hydroxyhexanoycarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine hydroxyhexanoycarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

3-Hydroxyhexanoyl-L-carnitine

3-Hydroxyhexanoyl-L-carnitine

C13H25NO5 (275.1733)


   

4-Hydroxyhexanoycarnitine

4-Hydroxyhexanoycarnitine

C13H25NO5 (275.1733)


   

(5R)-5-Hydroxyhexanoylcarnitine

(5R)-5-Hydroxyhexanoylcarnitine

C13H25NO5 (275.1733)


   

3-(1-Piperidinyl)-1-(4-propan-2-yloxyphenyl)-1-propanone

3-(1-Piperidinyl)-1-(4-propan-2-yloxyphenyl)-1-propanone

C17H25NO2 (275.1885)


   

3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide

3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide

C14H21N5O (275.1746)


   

MGK-264

N-(2-Ethylhexyl)-5-norbornene-2,3-dicarboximide

C17H25NO2 (275.1885)


   

Citronellyl anthranilate

Citronellyl anthranilate

C17H25NO2 (275.1885)


   

Hydroxyhexanoycarnitine

Hydroxyhexanoycarnitine

C13H25NO5 (275.1733)


   

O-hydroxyhexanoyl-L-carnitine

O-hydroxyhexanoyl-L-carnitine

C13H25NO5 (275.1733)


An O-acyl-L-carnitine that is L-carnitine having a hydroxyhexanoyl group as the acyl substituent in which the position of the hydroxy group is unspecified.

   
   
   

8-hydroxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[1,7a-e]azonin-13-one

8-hydroxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[1,7a-e]azonin-13-one

C17H25NO2 (275.1885)


   

(8s,9ar,13ar)-8-hydroxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[1,7a-e]azonin-13-one

(8s,9ar,13ar)-8-hydroxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[1,7a-e]azonin-13-one

C17H25NO2 (275.1885)


   

2-[6-(2-hydroxypropyl)-1-methylpiperidin-2-yl]-1-phenylethanone

2-[6-(2-hydroxypropyl)-1-methylpiperidin-2-yl]-1-phenylethanone

C17H25NO2 (275.1885)


   

(8s,9as,13as)-8-hydroxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[1,7a-e]azonin-13-one

(8s,9as,13as)-8-hydroxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[1,7a-e]azonin-13-one

C17H25NO2 (275.1885)


   

2-[(2r,6s)-6-[(2s)-2-hydroxypropyl]-1-methylpiperidin-2-yl]-1-phenylethanone

2-[(2r,6s)-6-[(2s)-2-hydroxypropyl]-1-methylpiperidin-2-yl]-1-phenylethanone

C17H25NO2 (275.1885)


   

1-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]propan-2-one

1-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]propan-2-one

C17H25NO2 (275.1885)


   

(2s)-1-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-3,6-dihydro-2h-pyridin-2-yl]propan-2-ol

(2s)-1-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-3,6-dihydro-2h-pyridin-2-yl]propan-2-ol

C17H25NO2 (275.1885)


   

(1'r,2r,7's,8'r,10's)-8'-ethyl-3-methyl-2'-azaspiro[furan-2,9'-tricyclo[5.5.0.0²,¹⁰]dodecan]-5-one

(1'r,2r,7's,8'r,10's)-8'-ethyl-3-methyl-2'-azaspiro[furan-2,9'-tricyclo[5.5.0.0²,¹⁰]dodecan]-5-one

C17H25NO2 (275.1885)


   

6-methyl-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione

6-methyl-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione

C17H25NO2 (275.1885)


   

4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohexan-1-one

4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohexan-1-one

C17H25NO2 (275.1885)


   

1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-3,6-dihydro-2h-pyridin-2-yl]propan-2-ol

1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-3,6-dihydro-2h-pyridin-2-yl]propan-2-ol

C17H25NO2 (275.1885)


   

1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]propan-2-one

1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]propan-2-one

C17H25NO2 (275.1885)


   

1-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]propan-2-one

1-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]propan-2-one

C17H25NO2 (275.1885)


   

(8r,9as,13as)-8-hydroxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[1,7a-e]azonin-13-one

(8r,9as,13as)-8-hydroxy-4,11-dimethyl-1h,2h,3h,5h,6h,8h,9h,9ah,10h-indeno[1,7a-e]azonin-13-one

C17H25NO2 (275.1885)


   

(2s)-1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-3,6-dihydro-2h-pyridin-2-yl]propan-2-ol

(2s)-1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-3,6-dihydro-2h-pyridin-2-yl]propan-2-ol

C17H25NO2 (275.1885)


   

(2r)-1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-ol

(2r)-1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-ol

C17H25NO2 (275.1885)


   

(2s)-2-{[(3r)-1,3-dihydroxydecylidene]amino}-3-hydroxypropanoic acid

(2s)-2-{[(3r)-1,3-dihydroxydecylidene]amino}-3-hydroxypropanoic acid

C13H25NO5 (275.1733)


   

(2e,4e,8z,10e,12e)-n-(2-hydroxypropan-2-yl)tetradeca-2,4,8,10,12-pentaenimidic acid

(2e,4e,8z,10e,12e)-n-(2-hydroxypropan-2-yl)tetradeca-2,4,8,10,12-pentaenimidic acid

C17H25NO2 (275.1885)


   

(1s,4r,6r,9r)-6-methyl-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione

(1s,4r,6r,9r)-6-methyl-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecane-2,8-dione

C17H25NO2 (275.1885)


   

1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-ol

1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-ol

C17H25NO2 (275.1885)